Plasma Test Launches for Rapid Detection of Mold Infections
The plasma-based test detects cell-free DNA from 14 mold species and delivers results in less than 24 hours, according to the company.
The plasma-based test detects cell-free DNA from 14 mold species and delivers results in less than 24 hours, according to the company.
The collaboration will combine New Day's liquid biopsy technology with Daisy Genomics' physics-based sequencing platform to advance early CRC screening.
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity's impact on Alzheimer's pathology.
The biotechnology company's integrated screening approach combines whole-genome sequencing, imaging, and multiple biomarker tests to enable early detection.
The tests mark the first rapid antigen diagnostics to achieve WHO prequalification status for SARS-CoV-2 detection.
The cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.
As early peanut introduction becomes more common, component testing is playing a larger role in distinguishing allergy from sensitization.
The test measures two sugar alcohols to detect SORD-related neuropathy, which standard genetic tests sometimes miss.
Research finds lysophosphatidylcholines either promote or protect against disease depending on APOE ε4 gene status, with implications for personalized treatments.
The automated system uses ion exchange HPLC technology to deliver A1c results while detecting common hemoglobin variants.
The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
The eight-minute test also shortened hospital stays by nearly two days at Froedtert Hospital, reinforcing previous multi-site evidence.